Harpoon Therapeutics, Inc. (HARP) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 7 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for HARP is $700.00, representing a +2,942.2% upside from the current price of $23.01. Price targets range from a low of $700.00 to a high of $700.00.
